IRIS
PIERRI, IVANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.628
AS - Asia 935
NA - Nord America 743
SA - Sud America 64
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 5
OC - Oceania 4
Totale 11.430
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.466
US - Stati Uniti d'America 696
SG - Singapore 401
CN - Cina 233
VN - Vietnam 149
FR - Francia 73
BD - Bangladesh 70
BR - Brasile 39
HK - Hong Kong 25
DE - Germania 19
CA - Canada 13
FI - Finlandia 13
MX - Messico 12
NL - Olanda 11
GB - Regno Unito 10
AR - Argentina 9
CH - Svizzera 9
IQ - Iraq 7
JP - Giappone 7
IN - India 6
UA - Ucraina 6
EC - Ecuador 5
ID - Indonesia 5
ES - Italia 4
IE - Irlanda 4
PY - Paraguay 4
TH - Thailandia 4
TR - Turchia 4
AU - Australia 3
CO - Colombia 3
CR - Costa Rica 3
HN - Honduras 3
IR - Iran 3
JM - Giamaica 3
OM - Oman 3
PH - Filippine 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BZ - Belize 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
NI - Nicaragua 2
SA - Arabia Saudita 2
SV - El Salvador 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
PF - Polinesia Francese 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 11.379
Salva come PNG Salva come JPEG
Città #
Genova 6.153
Genoa 1.897
Rapallo 763
Vado Ligure 572
San Jose 221
Singapore 189
Ashburn 85
Lauterbourg 69
Ho Chi Minh City 46
New York 45
Hanoi 37
Beijing 31
Hong Kong 25
Los Angeles 22
Bordighera 20
Santa Clara 20
Frankfurt am Main 16
Helsinki 13
Chicago 11
Da Nang 10
Rome 9
Zurich 9
Amsterdam 8
Mexico City 8
Milan 8
Buffalo 6
Dallas 6
Naples 6
Tokyo 6
Biên Hòa 5
Haiphong 5
Montreal 5
Newark 5
Cincinnati 4
Miami 4
Philadelphia 4
Phoenix 4
Richmond 4
Tianjin 4
Turin 4
Baghdad 3
Bắc Giang 3
Can Tho 3
Dhaka 3
Dublin 3
Hamilton 3
Kyiv 3
Las Vegas 3
Lawrenceville 3
Memphis 3
Nashville 3
Orem 3
Pinehurst 3
São Paulo 3
Torres 3
Woodstock 3
Atlanta 2
Bari 2
Basra 2
Boardman 2
Bologna 2
Brooklyn 2
Cardiff 2
Charlotte 2
Chennai 2
City of London 2
Ciudad del Este 2
Council Bluffs 2
Des Moines 2
Greenville 2
Guatemala City 2
Hohenwald 2
Lansdowne 2
Leander 2
Lincoln 2
London 2
Louisville 2
Lucca 2
Madrid 2
Manchester 2
Medford 2
Milwaukee 2
Mount Sterling 2
Nairobi 2
Ninh Bình 2
Norfolk 2
Nuremberg 2
Orland Park 2
Paris 2
Pasadena 2
Piscataway 2
Porto Alegre 2
Quito 2
Riyadh 2
San Francisco 2
San Pedro Sula 2
San Salvador 2
Seeb 2
Staten Island 2
Sydney 2
Totale 10.495
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 326
APO866 activity in hematologic malignancies: a preclinical in vitro study. 252
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 228
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 219
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 210
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 200
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 199
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 191
Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. 181
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 180
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 179
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. 177
Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors 176
T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions. 174
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia 171
First line therapy with Fludarabine combinations in 42 patients with either post-myelodysplastic syndrome or therapy related acute myeloid leukaemia. 171
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 170
Analysis of the role of xenogeneic antigens in the proliferation of human T cells stimulated with autologous non-T cells and phytohemagglutinin-activated T cells. 169
Essential Thrombocythemia: The Dermatologic Point of View 169
Evidence for killing of Mesenchymal Stem Cells (MSC) by autologous natural killer lymphocytes. 169
Combination of liposomal Daunorubicin, Fludarabine, and Cytarabine (FLAD) in patients with poor- risk acute leukemia. 168
Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions. 168
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 165
Thalidomide in agnogenic and secondary myelofibrosis 161
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 154
Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia 153
Acute tuberculous septicemia. 152
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. 151
Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells 150
Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia 150
An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma. 149
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: A feasible and effective salvage treatment for lymphoid malignancies 148
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia. 147
Human T lymphocytes in aging and malignancy: abnormalities in PHA-induced Ia antigen expression and in functional activity in autologous and allogeneic MLR. 147
T-lymphocytes phenotype and functions in patients with head and neck cancer. 146
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis. 146
[Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)]. 146
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 146
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. 142
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients 142
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 140
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience. 140
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. 133
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases 133
Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. 132
New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting. 132
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B 131
Decreased lymphocyte blastogenesis, IL2 production and NK activity following nifedipine administration to healthy humans. 131
In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand 130
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin’s lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation 129
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. 128
Deficiency of the autologous mixed lymphocyte reactions of non-T/T and T/T type in intravenous drug abusers infected by the human immunodeficiency virus (HIV). 127
[Remarks on rupture of the heart in recent myocardial infarct]. 127
PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions. 124
Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. 124
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. 119
Plasmaexchange plus immunoglobulins for treatment of hypergammaglobulinaemic patients with AIDS and AIDS-related complex (ARC). 119
Lymphocytapheresis in the treatment of rheumatoid arthritis: clinical and immunological studies. 118
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. 118
Role of normal adherent cells in the regulation of the autologous mixed lymphocyte reactions in humans. 118
Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. 118
Human autologous mixed lymphocyte reactions (a review). 115
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates pro-apoptotic signals in chronic lymphocytic leukemia B cells 115
[Plasmacytoid lymphoma of the lung. Presentation of a case and review of the literature]. 111
In vitro enhancement of the proliferative response of human T cells to autologous non-T cells by hydralazine. 109
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. 106
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia. 106
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa 105
[Granulomatous giant-cell endometritis due to talc]. 104
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly. 103
Expression of HLA-class II antigens and proliferative capacity in autologous mixed lymphocyte reactions of human T lymphocytes exposed in vitro to alpha-endorphin. 103
CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells cdan be targeted with ligands to induce apoptosis 101
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. 99
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method. 96
Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? 96
GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly. 92
Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer. 88
Thiol containing antioxidant drugs and the human immune system. 87
Immunocompetence in lung cancer patients: analysis of serological and cellular parameters. 81
Totale 11.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.356
article - articoli 33.356
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022943 27 73 48 111 30 60 77 206 34 88 36 153
2022/2023939 109 72 16 103 166 168 5 67 155 1 71 6
2023/2024485 27 62 8 51 45 111 24 23 20 7 30 77
2024/20251.344 19 106 41 78 210 151 111 206 40 69 152 161
2025/20262.241 272 47 66 149 301 213 390 101 199 212 137 154
2026/2027217 217 0 0 0 0 0 0 0 0 0 0 0
Totale 11.430